YOLFTbeta
Arcoma AB

Arcoma AB

ARCOMA · ST · Healthcare / Medical Devices

8.00SEK-0.70 (-8.05%)

Price History

Full chart

Market Stats

Previous Close8.70
Open8.70
Day Range7.96 – 8.72
52-Week Range6.16 – 10.05
Volume5.88K
Market Cap107.03M
P/E (TTM)27.70
Forward P/E17.27
EPS0.27
Dividend Yield0.00%
Beta0.64
50-Day Avg8.07
200-Day Avg8.10

About

Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanced remote control, form pad, hand control, compression belt, detector holder, foot control, lateral armrest, patient handgrip, mattress, scatter correction software, battery charger, battery pack, and stitching screen. It manufactures x-ray equipment under the Canon and Konica Minolta brand name. The company sells its products through resellers and OEM customers. Arcoma AB was incorporated in 1990 and is based in Växjö, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Mattias Leire
  • Employees33
  • HeadquartersAnnavägen 1, Växjö, Sweden, 352 46, Sweden
  • Websitehttps://www.arcoma.se

Leadership

  • Mr. Mattias LeireChief Executive Officer · b. 1981
  • Mr. Goran EdwallInterim Chief Financial Officer
  • Mr. Andre MalmbergChief Operating Officer · b. 1988
  • Daniel WarawasowskiGlobal Sales Director · b. 1982

Financials

Income Statement

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue147.66M101.31M130.43M123.28M102.08M91.85M119.47M133.67M117.42M117.13M125.05M163.01M156.81M130.80M
Growth (%)--31.39%+28.74%-5.48%-17.20%-10.02%+30.07%+11.89%-12.16%-0.24%+6.76%+30.36%-3.81%-16.59%
Cost of Revenue96.59M58.96M75.06M73.27M58.56M55.05M72.70M81.78M72.17M75.48M74.60M105.10M94.20M123.94M
Gross Profit51.07M42.35M55.37M50.02M43.52M36.80M46.77M51.90M45.25M41.65M50.45M57.91M62.61M6.86M
Gross Margin34.59%41.80%42.45%40.57%42.63%40.07%39.15%38.82%38.54%35.56%40.34%35.53%39.93%5.24%
Operating Expense51.66M52.26M54.79M56.22M56.40M46.79M47.16M42.80M42.96M49.10M47.32M53.25M48.95M-1.82M
Operating Income-590.66K-9.91M575.00K-6.20M-12.88M-9.99M-383.00K9.10M2.29M-7.45M3.13M4.66M13.65M8.68M
Operating Margin-0.40%-9.78%0.44%-5.03%-12.62%-10.88%-0.32%6.81%1.95%-6.36%2.50%2.86%8.71%6.64%
EBITDA2.86M-7.52M1.94M1.49M-3.81M-4.09M1.13M10.79M4.97M-6.66M4.68M6.11M21.96M16.02M
EBITDA Margin1.94%-7.43%1.49%1.21%-3.74%-4.45%0.95%8.08%4.24%-5.68%3.74%3.75%14.01%12.25%
Net Income-3.23M-11.62M914.00K-6.45M-11.65M-9.82M-1.59M6.61M1.36M-7.47M1.90M2.56M11.18M5.03M
Net Income Margin-2.19%-11.47%0.70%-5.23%-11.41%-10.69%-1.33%4.94%1.16%-6.38%1.52%1.57%7.13%3.85%
R&D-----4.91M4.01M2.50M1.84M4.63M4.94M6.50M7.02M-
R&D as % of Total Revenue-----5.34%3.36%1.87%1.56%3.95%3.95%3.99%4.48%-
Interest Expense2.64M1.80M3.56M1.33M893.00K585.00K491.00K403.00K539.00K760.00K902.00K1.39M260.00K118.00K
Interest Expense % of Total Revenue1.79%1.78%2.73%1.08%0.87%0.64%0.41%0.30%0.46%0.65%0.72%0.85%0.17%0.09%

Balance Sheet

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets68.49M70.87M79.21M84.25M71.25M68.11M76.27M83.33M95.03M79.27M100.33M81.96M80.46M96.65M
Total Liabilities44.35M58.35M37.48M34.34M33.90M27.28M37.24M38.14M45.50M35.23M54.46M33.30M21.13M21.92M
Total Equity24.14M12.52M41.73M49.92M37.35M40.83M39.03M45.19M49.53M44.04M45.88M48.66M59.33M74.73M
Cash80.44K359.75K385.00K7.21M5.15M4.45M7.81M2.20M8.58M4.83M9.66M5.00M13.38M35.32M
Total Debt10.88M23.55M12.56M13.13M16.29M1.79M13.35M7.27M17.01M16.61M25.09M3.87M59.00K90.00K
Net Debt10.80M23.19M12.17M5.92M11.14M-2.66M5.54M5.07M8.42M11.78M15.43M-1.13M-13.38M-35.23M

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.27M-11.82M-828.00K-4.95M-4.67M-8.91M45.00K11.10M6.85M-1.93M-179.00K19.16M18.84M18.72M
Investing Cash Flow-5.06M-9.35M-4.50M-4.96M-876.00K5.39M-916.00K-11.13M-11.70M-4.19M-4.17M-2.55M-6.78M-5.62M
Financing Cash Flow15.08M21.45M5.04M16.71M3.16M2.92M4.26M-6.08M11.23M2.40M9.65M-21.22M-3.87M10.36M
Capital Expenditure5.40M9.41M5.46M4.96M876.00K3.12M916.00K11.13M11.70M4.19M4.17M2.55M6.78M5.62M
Free Cash Flow-15.67M-21.23M-6.28M-9.90M-5.54M-12.03M-871.00K-28.00K-4.86M-6.12M-4.35M16.61M12.06M13.10M
FCF to OCF152.63%179.55%758.94%200.14%118.77%134.96%-1935.56%-0.25%-70.92%316.77%2429.05%86.68%64.02%69.96%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Feb 22, 2019May 23, 2019Aug 22, 2019Nov 19, 2019Feb 21, 2020May 20, 2020Aug 20, 2020Nov 12, 2020Feb 18, 2021May 24, 2021Aug 25, 2021Oct 28, 2021Feb 10, 2022Apr 28, 2022Aug 17, 2022Oct 27, 2022Feb 9, 2023Apr 27, 2023Aug 17, 2023Oct 26, 2023Jan 29, 2024Apr 25, 2024Aug 15, 2024Oct 24, 2024Feb 13, 2025Apr 29, 2025Aug 21, 2025Oct 23, 2025Feb 12, 2026Apr 27, 2026Aug 20, 2026
EPS Estimate----------------------------------------0.200.100.150.17--
EPS Actual0.10-0.84-0.270.09-0.75-0.44-0.080.15-0.10-0.32-0.440.02-0.130.060.01-0.060.050.200.190.060.310.180.08-0.460.150.08-0.24-0.56-0.090.110.110.02-0.180.030.150.190.340.270.170.050.160.000.110.100.060.02
Surprise-----------------------------------------20.00%-99.70%-26.67%-41.18%--
Timing---------------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap107.03M
Enterprise Value86.01M
Trailing P/E27.70
Forward P/E17.27
Price / Sales0.84
Price / Book1.45
EPS0.27
Book Value5.30
Revenue (TTM)127.27M
Gross Profit (TTM)50.46M
EBITDA3.85M
Profit Margin3.23%
Operating Margin0.96%
Return on Equity5.99%
Return on Assets3.37%
Shares Outstanding14.31M
Shares Float11.93M
Beta0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 21, 201536:35